SA
STOCK ALARM
STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
Workflows
Lists
Find Stocks
The Market
Charts
Research
Advisor
⌘J
GLUE
(GLUE)
GLUE
Overview
Intelligence
Chart
Historical Prices
Fundamentals
Key Metrics
Earnings
Growth
Analysts
News
Financials
Insiders
Institutional
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$1.30B
+153.9%
P/E Ratio
-33.72
-378.0%
P/S Ratio
10.53
+55.3%
ROE
-16.57%
+49.2%
ROIC
-13.56%
+52.3%
FCF Yield
-2.11%
-128.5%
Debt/Equity
0.17
-12.2%
Current Ratio
6.12
+154.6%
Interest Coverage
0.00x
Per Share
Revenue/Share
$1.49
+45.5%
Net Income/Share
$-0.46
+52.7%
Operating CF/Share
$-0.27
-148.3%
Free CF/Share
$-0.33
-164.4%
Cash/Share
$4.54
-9.8%
Book Value/Share
$2.81
-7.0%
Tangible Book/Share
$2.81
-7.0%
Equity/Share
$2.81
-7.0%
Interest Debt/Share
$0.47
-18.4%
Valuation
Market Cap
$1.30B
+153.9%
Enterprise Value
$1.21B
+265.7%
P/E Ratio
-33.72
-378.0%
P/S Ratio
10.53
+55.3%
P/OCF Ratio
-57.13
-567.8%
P/FCF Ratio
-47.37
-451.0%
P/B Ratio
5.59
+142.9%
P/TB Ratio
5.59
+142.9%
EV/Sales
9.80
+123.6%
EV/EBITDA
-26.43
-482.1%
Profitability
Earnings Yield
-2.97%
+79.1%
FCF Yield
-2.11%
-128.5%
ROE
-16.57%
+49.2%
ROIC
-13.56%
+52.3%
Return on Tangible Assets
-8.61%
+48.0%
Capital Allocation
CapEx/OCF
-20.62%
-317.1%
CapEx/Revenue
3.80%
-27.9%
CapEx/Depreciation
0.56
+14.5%
SBC/Revenue
15.25%
-36.4%
Balance Sheet
Debt/Equity
0.17
-12.2%
Debt/Assets
0.09
-10.3%
Net Debt/EBITDA
1.98
-20.5%
Current Ratio
6.12
+154.6%
Interest Coverage
0.00x
Income Quality
0.59
+202.2%
Efficiency
Days Sales Outstanding
14 days
+1525.9%
Days Payables Outstanding
155 days
-80.0%
Days Inventory
0 days
Receivables Turnover
26.89x
-93.8%
Payables Turnover
2.35x
+399.0%
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$1.99
-6.2%
Monte Rosa Therapeutics, Inc.
(GLUE)
$18.65
▲
1.07 (6.09%)
Chart
Share
Post on X
GLUE
Monte Rosa Therapeutics, Inc.
(GLUE)
NASDAQ
$18.65
▲
1.07 (6.09%)
Chart Studio
Share
GLUE
Show Technical Panel
Show S&P 500 Navigator
Loading chart...